Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Adcetris
Adcetris
Pfizer's blood cancer therapy Adcetris succeeds in late-stage trial
Reuters
Tue, 03/12/24 - 11:08 am
Pfizer
Adcetris
lymphoma
clinical trials
Seagen
Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission
BioSpace
Tue, 06/13/23 - 11:29 am
Seagen
Adcetris
Hodgkin's lymphoma
clinical trials
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
Sun, 06/4/23 - 04:31 pm
ASCO 2023 - Seagen
Bristol Myers Squibb
Adcetris
Opdivo
antibody-drug conjugate
Hodgkin's lymphoma
Pfizer to buy Seagen in $43B cancer drug deal
BioPharma Dive
Mon, 03/13/23 - 10:57 am
Pfizer
Seagen
M&A
lymphoma
Adcetris
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Thu, 02/16/23 - 11:27 am
Seagen
earnings
Merck
M&A
Adcetris
Seagen rolls out data for Adcetris combination to treat Hodgkin lymphoma
Endpoints
Mon, 12/12/22 - 10:39 pm
Seagen
Adcetris
ASH 2022
Hodgkin's lymphoma
Seagen's highest selling drug snags a label expansion for pediatric cancer patients
Endpoints
Sun, 11/13/22 - 07:01 pm
Seagen
Takeda
Adcetris
Hodgkin's lymphoma
FDA
pediatric
Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe
Yahoo/Zacks.com
Fri, 08/12/22 - 10:12 am
Seagen
Adcetris
Padcev
Tukysa
Tivdak
Merck
M&A
ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug
Fierce Pharma
Fri, 05/27/22 - 10:31 am
ASCO 2022
Seagen
Takeda
Adcetris
lymphoma
Seattle Genetics makes case it can be more than Adcetris
Biopharma Dive
Mon, 09/30/19 - 12:03 pm
Seattle Genetics
Adcetris
clinical trials
ESMO
enfortumab vedotin
Astellas
tucatinib
Seattle Genetics' Adcetris sales fall short yet again
Biopharma Dive
Sun, 04/28/19 - 12:19 pm
Seattle Genetics
earnings
Adcetris
Seattle Genetics' Adcetris Progresses Well Amid Competition
Yahoo/Zacks.com
Fri, 04/12/19 - 10:01 am
Seattle Genetics
Adcetris
relapsed Hodgkin lymphoma
relapsed systemic anaplastic large cell lymphoma
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
CP Wire
Mon, 02/11/19 - 10:20 am
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
Mon, 02/11/19 - 10:20 am
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Seattle Genetics down on light 2019 Adcetris sales guidance
BioCentury
Sat, 02/9/19 - 12:19 am
Seattle Genetics
Adcetris
ASH: Seattle Genetics rolls into latest Adcetris launch with double survival win
Fierce Biotech
Tue, 12/4/18 - 09:41 am
Seattle Genetics
Adcetris
ASH 2018
T-cell lymphoma
Adcetris gets speedy label expansion under FDA real-time pilot
BioCentury
Sat, 11/17/18 - 12:37 pm
FDA
Adcetris
Seattle Genetics
label expansions
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
CP Wire
Mon, 11/5/18 - 11:19 am
Seattle Genetics
Adcetris
T-cell lymphoma
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
Mon, 11/5/18 - 10:08 am
Seattle Genetics
Adcetris
T-cell lymphoma
Seattle Genetics sags as Adcetris sales miss target
BioCentury
Fri, 10/26/18 - 08:34 pm
Seattle Genetics
earnings
Adcetris
Pages
1
2
3
4
next ›
last »